BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37386691)

  • 1. Ellagic acid inhibits the formation of hypertrophic scars by suppressing TGF-β/Smad signaling pathway activity.
    Zhao ZJ; Wu DJ; Lv DL; Zhang BD; Chen L; Sun YQ
    Chem Biol Drug Des; 2023 Oct; 102(4):773-781. PubMed ID: 37386691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of Pathological Phenotype of Hypertrophic Scar Fibroblasts Via Coculture with Adipose-Derived Stem Cells.
    Deng J; Shi Y; Gao Z; Zhang W; Wu X; Cao W; Liu W
    Tissue Eng Part A; 2018 Mar; 24(5-6):382-393. PubMed ID: 28562226
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corilagin alleviates hypertrophic scars via inhibiting the transforming growth factor (TGF)-β/Smad signal pathway.
    Li Y; Yu Z; Zhao D; Han D
    Life Sci; 2021 Jul; 277():119483. PubMed ID: 33862115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALA-PDT promotes the death and contractile capacity of hypertrophic scar fibroblasts through inhibiting the TGF-β1/Smad2/3/4 signaling pathway.
    Qu Z; Chen Y; Du K; Qiao J; Chen L; Chen J; Wei L
    Photodiagnosis Photodyn Ther; 2024 Feb; 45():103915. PubMed ID: 38128289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of TRAP-1-like protein (TLP) gene on collagen synthesis induced by TGF-β/Smad signaling in human dermal fibroblasts.
    Wang X; Qian Y; Jin R; Wo Y; Chen J; Wang C; Wang D
    PLoS One; 2013; 8(2):e55899. PubMed ID: 23418473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of Smad protein by normal skin fibroblasts and hypertrophic scar fibroblasts in response to transforming growth factor beta1.
    Xie JL; Qi SH; Pan S; Xu YB; Li TZ; Liu XS; Liu P
    Dermatol Surg; 2008 Sep; 34(9):1216-24; discussion 1224-5. PubMed ID: 18616749
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Centella triterpenes cream as a potential drug for the treatment of hypertrophic scar through inhibiting the phosphorylation of STAT3: A network pharmacology analysis and in vitro experiments.
    Tan M; Wu D; Zhou Y; Duan B
    J Cosmet Dermatol; 2023 Dec; 22(12):3511-3519. PubMed ID: 37563868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Knockdown of lysyl oxidase like 1 inhibits the proliferation and pro-fibrotic effects of transforming growth factor-β1-induced hypertrophic scar fibroblasts.
    Ying M; Chen Y; Yuan B
    Can J Physiol Pharmacol; 2021 Dec; 99(12):1272-1279. PubMed ID: 34283938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Smad interacting protein 1 influences transforming growth factor-β
    Fang X; Hu X; Zheng Z; Tao K; Wang H; Guan H; Shi J; Ji P; Cai W; Bai X; Zhu X; Han J; Liu J; Hu D
    J Mol Histol; 2019 Dec; 50(6):503-514. PubMed ID: 31595443
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous peptide LYENRL prevents the activation of hypertrophic scar-derived fibroblasts by inhibiting the TGF-β1/Smad pathway.
    Ji X; Tang Z; Shuai W; Zhang Z; Li J; Chen L; Cao J; Yin W
    Life Sci; 2019 Aug; 231():116674. PubMed ID: 31344427
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Loureirin B inhibits fibroblast proliferation and extracellular matrix deposition in hypertrophic scar via TGF-β/Smad pathway.
    Bai X; He T; Liu J; Wang Y; Fan L; Tao K; Shi J; Tang C; Su L; Hu D
    Exp Dermatol; 2015 May; 24(5):355-60. PubMed ID: 25683490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of tetrandrine on the TGF-β-induced smad signal transduction pathway in human hypertrophic scar fibroblasts in vitro.
    Zunwen L; Shizhen Z; Dewu L; Yungui M; Pu N
    Burns; 2012 May; 38(3):404-13. PubMed ID: 21925794
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombospondin-4 critically controls transforming growth factor β1 induced hypertrophic scar formation.
    Qian W; Li N; Cao Q; Fan J
    J Cell Physiol; 2018 Jan; 234(1):731-739. PubMed ID: 30132849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SnoN residue (1-366) attenuates hypertrophic scars through resistance to transforming growth factor-β1-induced degradation.
    Sun GF; Li HC; Zhan YP; Zhang XF; Pan LY; Chen YF; Xu K; Feng DX
    Lab Invest; 2019 Dec; 99(12):1861-1873. PubMed ID: 31409891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platycodin D inhibits the proliferation and migration of hypertrophic scar-derived fibroblasts and promotes apoptosis through a caspase-dependent pathway.
    Yu Z; Li Y; Fu R; Xue Y; Zhao D; Han D
    Arch Dermatol Res; 2023 Jul; 315(5):1257-1267. PubMed ID: 36526799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Mechanism of transcriptional regulation of Meox1 by transforming growth factor β (1) and its effect on cell migration of adult human dermal fibroblasts].
    Wei ZY; Li HS; Zhou JY; Han C; Dong H; Wu YZ; He WF; Tian Y; Luo GX
    Zhonghua Shao Shang Za Zhi; 2020 Mar; 36(3):224-233. PubMed ID: 32241049
    [No Abstract]   [Full Text] [Related]  

  • 17. Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis.
    Li Y; Zhang J; Shi J; Liu K; Wang X; Jia Y; He T; Shen K; Wang Y; Liu J; Zhang W; Wang H; Zheng Z; Hu D
    Stem Cell Res Ther; 2021 Mar; 12(1):221. PubMed ID: 33789737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shikonin reduces TGF-β1-induced collagen production and contraction in hypertrophic scar-derived human skin fibroblasts.
    Fan C; Dong Y; Xie Y; Su Y; Zhang X; Leavesley D; Upton Z
    Int J Mol Med; 2015 Oct; 36(4):985-91. PubMed ID: 26239419
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Umbilical cord-derived mesenchymal stem cells exert anti-fibrotic action on hypertrophic scar-derived fibroblasts in co-culture by inhibiting the activation of the TGF β1/Smad3 pathway.
    Meng X; Gao X; Chen X; Yu J
    Exp Ther Med; 2021 Mar; 21(3):210. PubMed ID: 33574910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of ANGPT2 activates autophagy during hypertrophic scar formation via PI3K/AKT/mTOR pathway.
    Chen H; Xu K; Sun C; Gui S; Wu J; Wang S
    An Bras Dermatol; 2023; 98(1):26-35. PubMed ID: 36272879
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.